• PIONEER: First Phase 3 Data on Oral Semaglutide in Diabetes

    14 days ago - By Medscape

    Semaglutide, the first oral GLP-1 receptor agonist, shows HbA1c lowering and weight loss comparable to injectable version in type 2 diabetes; best efficacy confined to highest dose.
    Medscape Medical News
    Read more ...